Connect with us

Hi, what are you looking for?

Peptide Therapeutics Market Size Share Trends Demand and Forecast 2028

The Global Peptide Therapeutics Market is forecasted to value over USD 62 billion by 2028 end at a CAGR of over 6.4% during the forecast period 2022 to 2028.

Peptides, polypeptides, and proteins are chains of amino acids linked by peptide bonds. There is no clear distinction between these peptides, polypeptides, and proteins, but they are based on length. Polypeptides and proteins are long chains of amino acids, whereas peptides are short chains. Currently, peptides are being tested as therapeutics that are under 40 amino acids long, while polypeptides can be over 100 amino acids long, and proteins are made from polypeptide chains. The properties of a peptide are determined by which of the 21 amino acids it is composed of, with the properties of the amino acid side chains affecting its conformation, function, and function within the body. An amino acid peptide is a combination of two or more amino acids linked by peptide bonds. A peptide’s size determines its classification. The binding of peptides with receptors on the cell membrane helps treat disorders and diseases. A total of 150 peptides are currently being developed in clinical studies. Peptides have been used as therapeutics for many years, which has evolved the drug development process. Peptide  therapeutics are peptides or polypeptides (oligomers or short polymers of amino acids) used to treat diseases. Peptide therapeutics mimic the functions of hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives found in nature. As peptides can be metabolized by the body, peptide therapeutics are considered relatively safe and well-tolerated. A growing number of peptide therapeutic companies have recognized the potential of peptide pharmaceuticals to address unmet medical needs, as well as how this class of compounds can complement or even be preferred over small molecules and biologicals. In recent years, peptide drug discovery has experienced a revival of interest and scientific momentum. The market is being driven by rising prevalence of cancer and metabolic disorders, increased investments in research & development of innovative medications, and technological developments in peptide therapies. Various peptides or polypeptides are used to treat diseases. Different homologous derided peptides possess advantages, but also disadvantages. The body tolerates native peptides well, but they are easily broken down. In contrast, analog peptides can be designed to be harder to break down or to bind to other molecules, but this makes them less easily processed by natural machinery. Lastly, heterologous peptides carry the highest risk of side effects but are also the largest source of potential therapeutics. Currently, these peptides can perform a wide range of functions, leading to diverse therapeutic roles, and this pool of potential peptides will continue to grow with the advancement of bioinformatics and protein synthesis techniques.

The astute research report on Peptide Therapeutics market provides intricate details for analyzing appropriate parameters and valuable insights. The report offers extensive information about this business to help bring forth the growth potential of the market across various segments and provides the clients with a comprehensive analysis of factors like market size, market growth trends, competitive landscape, product utilization, regional growth prospects, and application potential, etc. The data provided in the report has been gathered from a wide variety of sources by using primary and secondary research. This Peptide Therapeutics research report also provides crucial insights into consumer behaviour, brand positioning, pricing analysis, and key player strategies. The market overview included in the Peptide Therapeutics research report incorporates critical factors procured from industry analysts, prominent players as well as trade and industrial organizations.

The report on Peptide Therapeutics market offers up-to-date information on the factors impeding the market growth which shall provide vendors with crucial insights into understanding the market dynamics thereby aiding the clients to sketch out a better business strategy. These factors will help them identify market growth opportunities. Furthermore, FutureWise research analysts provide timely assistance to their customers in understanding eccentric market parameters more effectively thereby leading to better decision-making.

Get a Sample of the Peptide Therapeutics Market Report @

The Peptide Therapeutics market research report is segmented –  by application, by type, by type of manufacturers, by route of administration, by synthesis technology, and by region. It also consists of insights regarding the revenue value and sales volume during the forecasted timeframe of 2022 to 2028.

Peptide Therapeutics Market Segmentation:

By Application

Cardiovascular Disorder

By Type


By Type of Manufacturers


By Route of Administration

Parenteral Route
Oral Route

By Synthesis Technology

Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

By Region

North America
Latin America
Middle East and Africa

Peptide Therapeutics Market Regional Analysis:

The report provides a complete evaluation of the potential amplification of the Peptide Therapeutics Market in pivotal geographic regions such as North America, Asia Pacific, Europe, Latin America and Middle East & Africa.

Competitive Landscape:                           

Some of the key market players are

Eli Lilly and Company
Pfizer, Inc.
Amgen, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceuticals Industries Ltd.
Lonza Inc.
Bristol-Myers Squibb (BMS)
AstraZeneca PLC
GlaxoSmithKline plc (GSK)
Novartis AG
Novo Nordisk A/S

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide an extensive analysis of the global Peptide Therapeutics market by application, by type, by type of manufacturers, by route of administration, by synthesis technology, and by region

To carter complex data and information on the characteristics influencing the market growth (drivers, restraints, opportunities, and industry-specific restraints)

To predict and assess micro-markets and the overall market

To anticipate the market size, in key geographical regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the Middle East and Africa

To estimate and inspect competitive landscape mapping- technological advancements, product launches, mergers and expansions

Flexible Delivery Model:

Our delivery model is flexible, so you can suggest changes to the content/scope as per your requirement

With purchase of any license of the report the customization Mobility Care offered is free of charge

You can directly forward your requirements/changes to the current table of content to:

About FutureWise Market Research:

We specialize in high-growth niche market research, offering flexibility, agility, and customized solutions for our clients. By providing our clients with market insights and consulting services, we ensure they stay on top of their industries for years to come.

FutureWise Market Research

Vinay T – Head of Business Development


UK: +44 141 628 9353 | USA: +1 347 709 4931


Written By

You may also like:

Tech & Science

Massive overseas and domestic investments offer Japan a chance to reclaim its tech crown.

Tech & Science

A part of the US surveillance program known as Section 702 allows intelligence agencies to conduct warrantless electronic monitoring of foreigners outside the United...


Roberto Cavalli dressed A-listers for decades and was known for his exotic animal prints and feather designs - Copyright AFP Brendan SmialowskiAlexandria SAGEItalian fashion...


Salman Rushdie, targeted for assassination since 1989 over his writing, had long wondered who would kill him.